Medicine traceability checking equipment

Abstract

The utility model relates to medicine traceability checking equipment. The medicine traceability checking device comprises a device body, the device body is provided with a placing plane, and the placing plane is used for placing medicines; the information reader is assembled on the equipment body, and the information reader is configured to read medicine information of the medicine in the placement plane; the joint arm comprises a first assembling part, an arm body part and a second assembling part, the arm body part is hinged to the first assembling part and the second assembling part, the first assembling part is suitable for being assembled with an equipment body in a matched mode, and the second assembling part is suitable for being assembled with the displayer in a matched mode. The display is connected with the equipment body through the articulated arm, so that the relative position relation between the equipment body and the display can be specifically adjusted according to an actual use space scene, and the effect that the medicine traceability checking equipment can be suitable for various space scenes is achieved.

Description

Technical Field

[0001] This application relates to the field of dispensing equipment technology, and in particular to a drug traceability and verification device. Background Technology

[0002] In the daily work of a hospital, the dispensing of medications in the outpatient and emergency pharmacies is of paramount importance, directly affecting the safety of patients' medication use.

[0003] Even within the same hospital, different dispensing windows may vary significantly in size and layout. In terms of related technologies, drug traceability and verification equipment can only be used for dispensing windows with relatively simple spatial scenarios, and is difficult to apply to dispensing windows with multiple spatial scenarios. Utility Model Content

[0004] Therefore, it is necessary to provide a drug traceability verification device to address the issue that drug traceability verification devices are only applicable to a limited range of spatial scenarios.

[0005] A drug traceability and verification device includes:

[0006] The equipment body has a placement surface for placing medicines.

[0007] Information reader, the information reader is mounted on the device body, and the information reader is configured to read the drug information of the drugs placed on the plane;

[0008] The articulated arm and the display, the articulated arm includes a first assembly part, an arm body part and a second assembly part, the arm body part is hinged to both the first assembly part and the second assembly part, wherein the first assembly part is adapted to be assembled with the device body and the second assembly part is adapted to be assembled with the display.

[0009] In one embodiment, the device body includes a stage and an assembly arm, with the assembly arm assembled to the stage.

[0010] The assembly arm includes a first assembly arm and a second assembly arm. The first assembly arm is assembled on the platform and is perpendicular to the placement plane.

[0011] The second assembly arm is vertically connected to the first assembly arm, and the second assembly arm is spaced apart from the placement plane along the length of the first assembly arm. The second assembly arm is used to assemble the information reader.

[0012] In one embodiment, the stage includes a first loading part and a second loading part, which are fitted together and perpendicular to each other, wherein at least a portion of the upper surface of the first loading part is a placement plane.

[0013] The first assembly arm is hinged to the end of the second loading part away from the placement plane, so that the first assembly arm has a vertical state and a horizontal state relative to the placement plane.

[0014] The second assembly arm is hinged to the end of the first assembly arm away from the second load-bearing part, so that the second assembly arm has a vertical state and a horizontal state relative to the first assembly arm.

[0015] In one embodiment, the second carrier section has an internal accommodating space for arranging some components of the drug traceability and verification equipment.

[0016] In one embodiment, the first assembly part is assembled with the first assembly arm.

[0017] In one embodiment, the information reader includes an optical signal scanner and / or a camera, enabling the information reader to be configured to read image information carriers in the outer packaging of the medicine.

[0018] In one embodiment, the articulated arm further includes a first pin, and the first assembly part and the arm body part are assembled by the first pin.

[0019] The articulated arm also includes a second pin, and the second assembly part and the arm body part are assembled by the second pin.

[0020] In one embodiment, the arm body includes at least one single arm body;

[0021] The number of single arms is configured to be multiple, with two adjacent single arms hinged together, and along the length direction of the arm body, the single arms at both ends of the arm body are respectively assembled with the first assembly part and the second assembly part.

[0022] In one embodiment, the arm body further includes at least one third pin, and two adjacent single arms are assembled by the third pin.

[0023] In one embodiment, the drug traceability verification device further includes a controller, which is mounted on the device body and is signal-connected to the information reader and the display. The controller is also configured to be signal-connected to at least one database.

[0024] The aforementioned drug traceability verification equipment features an information reader that can quickly and accurately scan drugs placed on a flat surface, improving both scanning speed and accuracy. Furthermore, because the display is connected to the equipment body via an articulated arm, the relative positions of the equipment body and the display can be adjusted according to the specific space requirements, making the equipment suitable for various spatial scenarios. Attached Figure Description

[0025] Figure 1 This is a perspective view of a drug traceability verification device according to an embodiment of this application.

[0026] Figure 2 This is a front view of a drug traceability verification device in a certain state according to an embodiment of this application.

[0027] Figure 3 This is a top view of a drug traceability verification device in one state according to an embodiment of this application.

[0028] Figure 4 This is a front view of a drug traceability verification device according to an embodiment of this application in another state.

[0029] Figure 5 This is a top view of a drug traceability verification device according to an embodiment of this application in another state.

[0030] Figure 6 This is a front view of a drug traceability verification device according to another embodiment of this application.

[0031] Figure 7 This is a top view of a drug traceability verification device according to another embodiment of this application.

[0032] Figure 8 This is a side view of the device body in a certain state according to an embodiment of this application.

[0033] Figure 9 This is a side view of the device body in another state according to an embodiment of this application.

[0034] Figure label:

[0035] 100. Drug traceability and verification equipment; 1. Equipment body; 10. Placement plane; 11. Carrying platform; 111. First carrying section; 112. Second carrying section; 12. Assembly arm; 121. First assembly support arm; 122. Second assembly support arm; 2. Articulated arm; 21. First assembly section; 22. Arm body section; 220. Single arm body; 221. First single arm body; 222. Second single arm body; 23. Second assembly section; 241. First pin; 242. Second pin; 243. Third pin; 3. Display. Detailed Implementation

[0036] To make the above-mentioned objectives, features, and advantages of this application more apparent and understandable, the specific embodiments of this application are described in detail below with reference to the accompanying drawings. Many specific details are set forth in the following description to provide a thorough understanding of this application. However, this application can be implemented in many other ways different from those described herein, and those skilled in the art can make similar modifications without departing from the spirit of this application. Therefore, this application is not limited to the specific embodiments disclosed below.

[0037] In the description of this application, it should be understood that if terms such as "center", "longitudinal", "lateral", "length", "width", "thickness", "upper", "lower", "front", "rear", "left", "right", "vertical", "horizontal", "top", "bottom", "inner", "outer", "clockwise", "counterclockwise", "axial", "radial", "circumferential" appear, these terms indicate the orientation or positional relationship based on the orientation or positional relationship shown in the accompanying drawings, and are only for the convenience of describing this application and simplifying the description, and do not indicate or imply that the device or element referred to must have a specific orientation, or be constructed and operated in a specific orientation, and therefore should not be construed as a limitation of this application.

[0038] Furthermore, where the terms "first" and "second" appear, these terms are for descriptive purposes only and should not be construed as indicating or implying relative importance or implicitly specifying the number of technical features indicated. Thus, a feature defined with "first" or "second" may explicitly or implicitly include at least one of that feature. In the description of this application, where the term "multiple" appears, "multiple" means at least two, such as two, three, etc., unless otherwise explicitly specified.

[0039] In this application, unless otherwise expressly specified and limited, the terms "installation," "connection," "joining," and "fixing," etc., should be interpreted broadly. For example, they can refer to a fixed connection, a detachable connection, or an integral part; they can refer to a mechanical connection or an electrical connection; they can refer to a direct connection or an indirect connection through an intermediate medium; they can refer to the internal communication of two components or the interaction between two components, unless otherwise expressly limited. Those skilled in the art can understand the specific meaning of the above terms in this application based on the specific circumstances.

[0040] In this application, unless otherwise expressly specified and limited, the use of descriptions such as "above" or "below" the second feature indicates that the first and second features are in direct contact or indirect contact via an intermediate medium. Furthermore, "above," "on top of," and "over" the second feature can mean that the first feature is directly above or diagonally above the second feature, or simply that the first feature is at a higher horizontal level than the second feature. Similarly, "below," "below," and "under" the second feature can mean that the first feature is directly below or diagonally below the second feature, or simply that the first feature is at a lower horizontal level than the second feature.

[0041] It should be noted that if an element is referred to as being "fixed to" or "set on" another element, it can be directly on the other element or there may be an intervening element. If an element is considered to be "connected to" another element, it can be directly connected to the other element or there may be an intervening element. If so, the terms "vertical," "horizontal," "upper," "lower," "left," "right," and similar expressions used in this application are for illustrative purposes only and do not represent the only possible implementation.

[0042] See Figure 1 As shown, the drug traceability verification device 100 according to this application includes a device body 1, an information reader, an articulated arm 2, and a display 3. The information reader is mounted on the device body 1, and the display 3 is mounted on the device body 1 via the articulated arm 2.

[0043] The placement plane 10 is used to place medicines, and the information reader mounted on the device body 1 is used to read the medicine information of the medicines located on the placement plane 10, so that the medicine traceability verification device 100 can be used to verify the medicine information, avoiding medication errors caused by human factors. Furthermore, the verification results of the medicines by the medicine traceability verification device 100 are displayed on the display 3, so that pharmacists can see the verification results by checking the display 3, allowing them to determine whether the medication was dispensed correctly. This not only enables accurate verification of medicine information and rapid completion of medication verification, but also reduces medication errors caused by human factors.

[0044] For example, the information reader is used to read the traceability code of a drug. By reading the traceability code, data such as the drug's name, specifications, quantity, and manufacturer can be obtained. Additionally, the drug traceability verification device 100 can also connect to the HIS system. After reading the drug's traceability code through the information reader, the drug traceability verification device 100 can upload the relevant information to the HIS system for later traceability. It should be added that the HIS system is a core component of hospital information system construction. It is a comprehensive information system designed and developed for the management and operation of the hospital. By integrating data and information from various departments and business processes within the hospital, the HIS system achieves information sharing and collaborative work within the hospital, improving the quality and efficiency of medical services.

[0045] The articulated arm 2 includes a first mounting portion 21, an arm body portion 22, and a second mounting portion 23. The arm body portion 22 is hinged to both the first mounting portion 21 and the second mounting portion 23, allowing the first mounting portion 21 and the second mounting portion 23 to rotate relative to the arm body portion 22. Furthermore, the first mounting portion 21 is adapted to assemble with the device body 1 to fix the articulated arm 2 to the device body 1, and the second mounting portion 23 is adapted to assemble with the display 3 to fix the display 3 to the articulated arm 2, thereby achieving the effect of mounting the display 3 to the device body 1 via the articulated arm 2.

[0046] For example, in combination Figures 2 to 5 As shown, since the first assembly part 21 is hinged to the arm body part 22, the arm body part 22 can rotate relative to the equipment body 1. For example... Figure 2 and Figure 3 As shown, in the width direction of the drug traceability verification device 100, the display 3 is located on the right side of the device body 1, and at this time in the length direction of the drug traceability verification device 100, the display surface of the display 3 is set to face forward.

[0047] By driving the arm body 22 to rotate relative to the first assembly part 21, the display 3 is adjusted to the left side of the device body 1 in the width direction of the drug traceability verification device 100, and at this time, the display surface of the display 3 is set to face rearward in the length direction of the drug traceability verification device 100. Then, by driving the second assembly part 23 to rotate relative to the arm body 22, that is, by driving the display 3 to rotate relative to the arm body 22, the display surface of the display 3 can be set to face forward. For example Figure 4 and Figure 5 The status of the drug traceability verification equipment 100 is shown in the image.

[0048] It should be further explained that in the above example, the display 3 can only be adjusted left and right in the width direction of the drug traceability verification device 100, and the display surface of the display 3 can be adjusted forward and backward in the length direction of the drug traceability verification device 100. However, the articulated arm 2 according to this application includes a first assembly part 21, an arm body part 22, and a second assembly part 23, and the arm body part 22 is hinged to both the first assembly part 21 and the second assembly part 23. This means that the positional relationship of the display 3 relative to the device body 1 is not limited to the above example, and the orientation of the display 3 is not limited to the above example. This also allows the display 3 to be adjusted according to the spatial scenario in which the drug traceability verification device 100 is applied, making the drug traceability verification device 100 applicable to various spatial scenarios.

[0049] For example, the different positional relationships between the dispensing machine track and the dispensing window result in different requirements for the placement of the mounting plane 10 and the display 3. Furthermore, based on these different positional relationships, the pharmacist's seat and the direction the pharmacist faces towards the display 3 will also differ. Since the display 3 according to this application is connected to the device body 1 via the articulated arm 2, the drug traceability verification device 100 can adjust the relative positional relationship between the device body 1 and the display 3 according to the actual usage space scenario, thus enabling the drug traceability verification device 100 to be applicable to various spatial scenarios.

[0050] See Figure 3 , Figure 5 and Figure 7 As shown, in some embodiments of this application, the articulated arm 2 further includes a first pin 241 and a second pin 242, wherein the first assembly part 21 and the arm body part 22 are assembled by the first pin 241 to achieve the effect of hinged connection between the first assembly part 21 and the arm body part 22, and the second assembly part 23 and the arm body part 22 are assembled by the second pin 242 to achieve the effect of hinged connection between the second assembly part 23 and the arm body part 22.

[0051] For example, in one example, a first assembly part 21 is provided with a first assembly hole, and an arm body part 22 is provided with a second assembly hole corresponding to and communicating with the first assembly hole. Both the first and second assembly holes are through holes without internal threads. The first pin member 241 includes a pin body and a nut body, the nut body being adapted to be screwed into the pin body. For instance, during the assembly process of the first assembly part 21 and the arm body part 22, the operator first aligns the first and second assembly holes to make them coaxial. Then, the operator inserts the pin body of the first pin member 241 through the coaxial and communicating first and second assembly holes, that is, the pin body simultaneously passes through both the first assembly part 21 and the arm body part 22. This restricts the relative positional relationship between the first assembly part 21 and the arm body part 22, preventing separation of the first assembly part 21 and the arm body part 22. Furthermore, the arm body part 22 can rotate relative to the first assembly part 21 around the axis of the pin body. Finally, the operator screws the nut body and the pin body together to prevent the pin body from separating from the first assembly part 21 and the arm body part 22, ensuring that the pin body effectively limits the movement of the first assembly part 21 and the arm body part 22. It should be noted that, in one example, the second pin part 242 may also include a pin body and a nut body. This allows the mating relationship between the arm body part 22 and the second assembly part 23 to be similar to the mating relationship between the first assembly part 21 and the arm body part 22, which will not be elaborated further here.

[0052] It should also be noted that, in the above example, the first pin 241 and the second pin 242 include a pin body and a nut body, and the nut body is screwed into the pin body. Therefore, according to the articulated arm 2 of this application, the first assembly part 21 and the arm body part 22 can not only rotate relative to each other, but also be disassembled and assembled. Similarly, the second assembly part 23 and the arm body part 22 can not only rotate relative to each other, but also be disassembled and assembled.

[0053] In addition, regarding the second assembly unit 23, it should be noted that the tilt angle of the display 3 can also be adjusted through the second assembly unit 23 so that the display 3 can be oriented towards the pharmacist in the height direction of the drug traceability verification equipment 100, thereby improving the visual effect.

[0054] See Figures 2 to 7 As shown, in some embodiments of this application, the arm body 22 includes at least one single arm 220. It can also be understood that the number of single arms 220 in the arm body 22 can be configured to be one or more. When the number of single arms 220 in the arm body 22 is configured to be multiple, adjacent single arms 220 are hinged to allow relative rotation between them. Furthermore, along the length of the arm body 22, the single arms 220 at both ends of the arm body 22 are respectively fitted with the first assembly part 21 and the second assembly part 23, thereby connecting the arm body 22 between the first assembly part 21 and the second assembly part 23.

[0055] For example, see Figures 2 to 5 As shown, the arm body 22 includes two single arm bodies 220 as an example. One single arm body 220 is the first single arm body 221, and the other single arm body 220 is the second single arm body 222. Further, along the length direction of the first single arm body 221, one end of the first single arm body 221 is hinged to the first assembly part 21, allowing the first assembly part 21 to rotate relative to it. The other end of the first single arm body 221 is hinged to the second single arm body 222, thus achieving the effect of hinged connection between the arm body 22 and the first assembly part 21. Additionally, along the length direction of the second single arm body 222, one end of the second single arm body 222 is hinged to the other end of the first single arm body 221, and the other end of the second single arm body 222 is hinged to the second assembly part 23, thus achieving the effect of connecting the arm body 22 between the first assembly part 21 and the second assembly part 23.

[0056] The arm body 22 is composed of multiple single arm bodies 220 hinged together in sequence. This design allows for flexible adjustment of the distance between the first assembly part 21 and the second assembly part 23 connected to both ends of the arm body 22. By adjusting this distance, the distance between the display 3 and the device body 1 also changes. Furthermore, any two hinged single arm bodies 220 can rotate relative to each other, which greatly enriches the relative positional relationship between the display 3 and the device body 1. With this feature, the drug traceability verification device 100 can be widely applied to diverse spatial scenarios, easily adapting to both narrow, confined corners and complex layouts.

[0057] See Figures 2 to 5 As shown, in some embodiments of this application, the arm body 22 further includes at least one third pin 243, and two adjacent single arms 220 are assembled by the third pin 243. The third pin 243 provides an additional and stable connection point between adjacent single arms 220. For example, during the use of the drug traceability verification device 100, the arm body 22 needs to frequently adjust the distance between the display 3 and the device body 1 and change their relative position. During this process, the single arms 220 will be subjected to various stresses and torques. The presence of the third pin 243 can effectively disperse these forces, preventing the connection between the single arms 220 from becoming loose, deformed, or even damaged due to uneven force, greatly enhancing the stability and reliability of the entire arm body 22 structure, and ensuring that the drug traceability verification device 100 maintains a good working condition during long-term use.

[0058] Furthermore, the third pin 243 can be a standardized connector with the first pin 241 and the second pin 242 mentioned above. For example, the first pin 241, the second pin 242, and the third pin 243 all include a pin body and a nut body, and their specifications are uniform. Due to the standardization of components, production costs are reduced, and the assembly efficiency of operators can be improved during the assembly process.

[0059] The two adjacent single-arm bodies 220 are detachably assembled by the third pin 243, so that the maximum length of the arm body 22 can be changed by increasing or decreasing the number of single-arm bodies 220 in the arm body 22 during use. This makes the drug traceability verification equipment 100 widely applicable to diverse spatial scenarios, whether it is a narrow and confined corner or a complex layout site, it can be easily adapted.

[0060] See Figures 1 to 7As shown, in some embodiments of this application, the device body 1 includes a platform 11 and an assembly arm 12, with the assembly arm 12 mounted on the platform 11. The assembly arm 12 may include a first assembly support arm 121 and a second assembly support arm 122. The first assembly support arm 121 is mounted on the platform 11 and is perpendicular to the placement plane 10. The second assembly support arm 122 is perpendicularly connected to the first assembly support arm 121, and is spaced apart from the placement plane 10 along its length. The second assembly arm 122 is used to assemble an information reader.

[0061] The information reader is installed in the second assembly arm 122, so that in the height direction of the drug traceability verification device 100, the information reader is spaced apart from the placement plane 10 and faces the placement plane 10 provided on the first carrier part 111, so that the information reader can be used to read the drug information of the drugs in the placement plane 10.

[0062] See Figures 1 to 9 As shown, in some embodiments of this application, the stage 11 includes a first loading portion 111 and a second loading portion 112, wherein the first loading portion 111 and the second loading portion 112 are vertically assembled, and at least a portion of the upper surface of the first loading portion 111 is a placement plane 10. A first mounting arm 121 is hinged to the end of the second loading portion 112 away from the placement plane 10, such that the first mounting arm 121 has a vertical state and a horizontal state relative to the placement plane 10. A second mounting arm 122 is hinged to the end of the first mounting arm 121 away from the second loading portion 112, such that the second mounting arm 122 has a vertical state and a horizontal state relative to the first mounting arm 121.

[0063] For example, in combination Figures 1 to 9 As shown, in the thickness direction of the first carrying portion 111, the second carrying portion 112 is disposed on the upper surface of the first carrying portion 111, and the second carrying portion 112 can be configured as a placement plane 10 for the unobstructed portion of the upper surface of the first carrying portion 111. It should be noted that this example uses the second carrying portion 112 disposed on the upper surface of the first carrying portion 111 as an example, but this application is not limited to this. For example, the second carrying portion 112 can be fixedly connected to the side surface of the first carrying portion 111.

[0064] The first assembly arm 121 is hinged to the end of the second carrying section 112 away from the placement plane 10. This can also be understood as the first assembly arm 121 being hinged to the upper surface of the second carrying section 112 in the height direction of the drug traceability verification equipment 100. Because the first assembly arm 121 and the second carrying section 112 are hinged, the first assembly arm 121 can rotate relative to the second carrying section 112. (See, for example...) Figure 8 and Figure 9 As shown, the first mounting arm 121 can rotate at a 90-degree angle relative to the second carrying part 112, so that the first mounting arm 121 has a vertical state and a horizontal state relative to the placement plane 10.

[0065] Furthermore, along the length of the first mounting arm 121, the second mounting arm 122 is hinged to the end of the first mounting arm 121 away from the second load-bearing portion 112. This can also be understood as the first mounting arm 121 connecting the second load-bearing portion 112 and the second mounting arm 122. Because the second mounting arm 122 is hinged to the first mounting arm 121, the second mounting arm 122 can rotate relative to the first mounting arm 121. (See, for example...) Figure 8 and Figure 9 As shown, the second assembly arm 122 can rotate at a 90-degree angle relative to the first assembly arm 121, so that the second assembly arm 122 has a horizontal state and a vertical state relative to the placement plane 10.

[0066] For example, see Figures 1 to 8 As shown, when the drug traceability verification device 100 is in use, the first assembly arm 121 is set perpendicular to the placement plane 10, and the second assembly arm 122 is set perpendicular to the first assembly arm 121, so that the second assembly arm 122 and the placement plane 10 are parallel to each other. It should be further noted that the information reader is located in the second assembly arm 122. Thus, in the height direction of the drug traceability verification device 100, the information reader is spaced apart from the placement plane 10, and the information reader faces the placement plane 10 located on the first carrying part 111, allowing the information reader to read the drug information of the drugs within the placement plane 10.

[0067] See also Figure 9 As shown, taking the drug traceability verification device 100 in its transport state as an example, since the first carrying part 111 and the second carrying part 112 are perpendicular to each other, and the first assembly arm 121 is hinged to the upper surface of the second carrying part 112, when the first assembly arm 121 is set parallel to the placement plane 10, the first assembly arm 121 and the placement plane 10 are spaced apart in the height direction of the drug traceability verification device 100, that is, the first assembly arm 121 and the placement plane 10 form a certain space in the height direction of the drug traceability verification device 100. Furthermore, since the second assembly arm 122 is hinged to the end of the first assembly arm 121 away from the second carrying part 112, adjusting the second assembly arm 122 to be parallel to the first assembly arm 121 allows the second assembly arm 122 to be housed within the space formed between the first assembly arm 121 and the placement plane 10.

[0068] Therefore, according to the device body 1 of this application, the device body 1 can have a usage state and a transportation state. When the device body 1 is in the usage state, the information reader provided in the second assembly arm 122 faces the placement plane 10 of the first loading part 111, so that the information reader can be used to read the drug information of the drug within the placement plane 10. And when the device body 1 is in the transportation state, the assembly arm 12 can be folded and stored to reduce the overall size of the device body 1.

[0069] In some embodiments of this application, the second carrying unit 112 forms an accommodating space for arranging some components of the drug traceability verification device 100. This accommodating space can house some of the components of the drug traceability verification device 100, bringing them together and improving the device's integration. This not only makes the device's appearance more concise and aesthetically pleasing but also reduces the extra space occupied by scattered components, making the overall size of the drug traceability verification device 100 more compact and easier to install and place in different spatial scenarios.

[0070] See Figures 2 to 7 As shown, in some embodiments of this application, the first assembly part 21 is assembled with the first assembly support arm 121. This can also be understood as the articulated arm 2 being assembled with the first assembly support arm 121 of the equipment body 1 to achieve the effect of assembling the articulated arm 2 onto the equipment body 1.

[0071] For example, such as Figures 2 to 7 As shown, in the width direction of the platform 11, the connection point between the first mounting arm 121 and the platform 11 is located in the middle of the platform 11. Since the display 3 is assembled with the device body 1 via the articulated arm 2, with a fixed distance between the first mounting part 21 and the second mounting part 23, the display 3 is symmetrically positioned on the left and right sides of the device body 1. This ensures that the distance between the display 3 and the placement plane 10 in the width direction of the platform 11 is equal. For irregular spatial shapes or special layout requirements, symmetrically designed devices have greater adaptability. For example, in a corner layout scenario, the device can adjust the display 3 to a suitable side of the drug traceability verification device 100 while maintaining a fixed distance from the placement plane 10, without affecting its operational performance due to space limitations. This allows the device to flexibly adapt to spaces of various shapes, improving its adaptability and practicality in different spatial scenarios.

[0072] In some embodiments of this application, the information reader includes an optical signal scanner and / or a camera, enabling the information reader to be configured to read image information carriers in the outer packaging of a pharmaceutical product. It can be understood that the information reader includes one of an optical signal scanner and a camera, or that the information reader includes both an optical signal scanner and a camera.

[0073] For example, in some examples of this application, the information reader includes both an optical signal scanner and a camera. This allows the information reader to work collaboratively with the optical signal scanner to improve its accuracy. For instance, when the information reader scans a barcode, the camera can provide a visual image of the barcode, while the optical signal scanner can provide information about the light reflection or transmission of the barcode. The combination of both allows for verification of barcode information from different angles. For example, the camera can capture an image of the barcode's appearance, including its shape, position, and surrounding packaging information, while the infrared scanner can acquire the infrared characteristics of the barcode. By comparing and analyzing these two types of information, it is possible to more accurately determine whether the barcode is complete, clear, and has not been tampered with, thus improving the accuracy and reliability of identification.

[0074] Furthermore, optical scanners offer better adaptability to various environments. In high-temperature, low-temperature, high-humidity, or dusty environments, optical scanners operate more stably than cameras that rely solely on visible light. For example, in low-temperature environments, frost or fog may occur, affecting the propagation of visible light, but the performance of the optical scanner may remain unaffected, still effectively scanning barcodes. In environments with complex lighting conditions, such as those with multiple different light sources or reflective surfaces, optical scanners can reduce these interference factors by using specific wavelengths of light, working in conjunction with cameras to ensure successful barcode recognition in diverse environments.

[0075] Optical scanners typically possess rapid scanning capabilities, acquiring the optical signal information of barcodes in a short time, while cameras simultaneously capture images. This parallel operation allows for the rapid acquisition of crucial barcode information while simultaneously obtaining more detailed image data, accelerating the entire barcode recognition process and increasing recognition speed. For large-scale pharmaceutical traceability and verification, this combination can improve efficiency while maintaining recognition accuracy, reducing the recognition time for each drug and enhancing overall work efficiency.

[0076] In some embodiments of this application, the drug traceability verification device 100 further includes a controller. The controller can be disposed within the accommodating space formed by the second carrying part 112, thereby achieving the effect of the controller being mounted on the device body 1. The controller is signal-connected to the information reader and the display 3, and is also configured to be signal-connected to at least one database. For example, the controller can be signal-connected to the pharmacy's drug database and HIS system, thus enabling information transmission between the drug traceability verification device 100 and the pharmacy's drug database and HIS system through the controller.

[0077] For example, the dispensing machine track transports the medicine to the pharmacist's position. The pharmacist removes the medicine from the dispensing machine track and places it on the placement plane 10 of the device body 1, allowing the information reader to scan the medicine and obtain its information. It should be noted that during the scanning process, because the medicine is placed statically on the device body 1, the situation where the information reader cannot scan the medicine due to movement is avoided, allowing the information reader to quickly complete the scanning process. For example, the information reader may be used to scan traceability codes on medicine packaging.

[0078] Because the information reader is connected to the controller via a signal link, the reader can send the read medication information to the controller. The controller can also interact with the HIS system to obtain prescription information that needs to be verified in real time. The controller compares the medication information with the patient's prescription information to confirm whether the identified medication matches the prescription and meets the prescription requirements. Medication information includes the medication name, specifications, quantity, and manufacturer. The controller utilizes advanced data mining and pattern recognition technologies to quickly and accurately analyze and process the read traceability code information, efficiently comparing it with information in the medication database and the HIS system.

[0079] Furthermore, since the controller is connected to the display 3, the display 3 can show the verification results, allowing pharmacists to check the results and confirm whether the medication was dispensed correctly. This not only enables accurate verification of drug information and rapid dispensing verification but also reduces dispensing errors caused by human factors. For example, the display screen may use different colors and text to provide prompts and remind pharmacists to take appropriate action. It should be noted that in some embodiments of this application, the display 3 can be a touch display.

[0080] Furthermore, the controller can also send the verification results and the read traceability code back to the HIS system to complete the synchronous sharing of data.

[0081] In summary, the drug traceability verification device 100 according to some embodiments of this application brings multiple advantages and improvements to pharmacies. Firstly, in terms of improving dispensing accuracy, the drug traceability verification device 100 ensures the correctness of drug dispensing, minimizing errors caused by human negligence and even achieving a zero-error rate, greatly protecting patient medication safety. Secondly, it excels in improving dispensing efficiency, quickly completing dispensing verification and traceability code reading. Each drug can be verified promptly, significantly reducing patient waiting time and improving pharmacy efficiency. Thirdly, ensuring the integrity of drug traceability is a crucial function. By accurately reading drug traceability codes, it achieves full-process traceability of drugs, facilitating rigorous monitoring of drug quality and origin. Fourthly, the drug traceability verification device 100 can reduce the burden on pharmacists, lowering their workload and freeing them from tedious verification work, allowing them to focus more on important tasks such as providing pharmaceutical services to patients, thus improving the quality and service level of pharmacists' work. Fifth, the Drug Traceability Verification Equipment 100 can also optimize the management of outpatient and emergency pharmacies. By using digital and intelligent methods, it improves the overall management level of the pharmacy, making pharmacy management more scientific and efficient. Finally, the Drug Traceability Verification Equipment 100 can effectively solve the problem of discrepancies between prescription and drug information. Through interaction with the HIS system, it can promptly detect and handle situations where prescriptions and dispensed drugs do not match, ensuring the accuracy of prescription execution and the standardization of drug dispensing, and avoiding medication risks caused by information discrepancies.

[0082] The technical features of the above embodiments can be combined in any way. For the sake of brevity, not all possible combinations of the technical features in the above embodiments are described. However, as long as there is no contradiction in the combination of these technical features, they should be considered to be within the scope of this specification.

[0083] The embodiments described above are merely illustrative of several implementation methods of this application, and while the descriptions are relatively specific and detailed, they should not be construed as limiting the scope of the patent application. It should be noted that those skilled in the art can make various modifications and improvements without departing from the concept of this application, and these all fall within the protection scope of this application. Therefore, the protection scope of this patent application should be determined by the appended claims.

Claims

1. A drug traceability and verification device, characterized in that, include: The device body has a placement surface for placing medicines. An information reader is mounted on the device body and is configured to read the drug information of the drug within the placement plane; The articulated arm and the display, the articulated arm including a first assembly part, an arm body part and a second assembly part, the arm body part being hinged to both the first assembly part and the second assembly part, wherein the first assembly part is adapted to be assembled with the device body and the second assembly part is adapted to be assembled with the display.

2. The drug traceability and verification equipment according to claim 1, characterized in that, The equipment body includes a platform and an assembly arm, with the assembly arm assembled to the platform. The assembly arm includes a first assembly arm and a second assembly arm. The first assembly arm is assembled to the platform and is perpendicular to the placement plane. The second assembly arm is perpendicularly connected to the first assembly arm, and the second assembly arm is spaced apart from the placement plane along the length direction of the first assembly arm. The second assembly arm is used to assemble the information reader.

3. The drug traceability and verification equipment according to claim 2, characterized in that, The platform includes a first loading section and a second loading section, which are assembled together, and the first loading section and the second loading section are perpendicular to each other, wherein at least a portion of the upper surface of the first loading section is the placement plane. The first assembly arm is hinged to the end of the second loading part away from the placement plane, so that the first assembly arm has a vertical state and a horizontal state relative to the placement plane. The second assembly arm is hinged to the end of the first assembly arm away from the second load-bearing part, so that the second assembly arm has a vertical state and a horizontal state relative to the first assembly arm.

4. The drug traceability and verification equipment according to claim 3, characterized in that, The second carrying section has an internal accommodating space for arranging some components of the drug traceability and verification equipment.

5. The drug traceability and verification equipment according to claim 2, characterized in that, The first assembly part is assembled with the first assembly support arm.

6. The drug traceability and verification equipment according to claim 1, characterized in that, The information reader includes an optical signal scanner and / or a camera, enabling the information reader to be configured to read image information carriers in the outer packaging of the medicine.

7. The drug traceability and verification equipment according to claim 1, characterized in that, The articulated arm also includes a first pin, and the first assembly part and the arm body part are assembled by the first pin. The articulated arm also includes a second pin, and the second assembly part and the arm body part are assembled by the second pin.

8. The drug traceability and verification equipment according to claim 7, characterized in that, The arm body includes at least one single arm body; The number of single arms is configured to be multiple, with two adjacent single arms hinged together, and along the length direction of the arm portion, the single arms at both ends of the arm portion are respectively assembled with the first assembly portion and the second assembly portion.

9. The drug traceability and verification equipment according to claim 8, characterized in that, The arm body also includes at least one third pin, and two adjacent single arms are assembled by the third pin.

10. The drug traceability and verification equipment according to any one of claims 1 to 9, characterized in that, Also includes: A controller is mounted on the device body and is signal-connected to the information reader and the display. The controller is also configured to be signal-connected to at least one database.

Images